NCT06765369 (MAP-Med) is a NA clinical trial of Mediterranean diet in Healthy, sponsored by University of British Columbia.

Who is sponsoring NCT06765369?

NCT06765369 is sponsored by University of British Columbia.

What drugs are being tested in NCT06765369?

Interventions in NCT06765369: Mediterranean diet, Westernized Diet.

Is NCT06765369 still recruiting?

NCT06765369 is currently not yet recruiting. Last updated 9 January 2025.

Last reviewed 2025-01-09 · How we verify

NCT06765369: MAP-Med

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

How the Mediterranean Diet Affects You: Predicting Responses Based on Your Microbiome

Not yet recruiting NA Last updated 9 January 2025

What this trial tests

NA trial testing Mediterranean diet in Healthy in 25 participants. Not yet recruiting.

Timeline

8 January 2025

Primary endpoint
31 December 2025

31 December 2026

Quick facts

Lead sponsor	University of British Columbia
Phase	NA
Status	Not yet recruiting
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	single
Primary purpose	treatment
Enrollment	25
Start date	8 January 2025
Primary completion	31 December 2025
Estimated completion	31 December 2026
Sites	1 location across Canada

Drugs / interventions tested

Mediterranean diet
Westernized Diet

Conditions studied

Healthy — all drugs for Healthy →

Sponsor

University of British Columbia

Who can join

Adults 20 to 50, any sex, with Healthy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

People respond differently to various diets-some may see significant benefits, while others may not. This project aims to personalize dietary recommendations by analyzing the gut microbiome to predict who will benefit most from the Mediterranean diet based on their unique biology, including their microbiome. The study focuses on answering these key questions: 1. Are there specific microbes that influence who is most likely to benefit from the Mediterranean diet? 2. What changes occur in the gut microbiome when healthy individuals follow a Mediterranean diet? To explore these questions, researchers will compare the effects of a Mediterranean diet to a Western-style diet. Participants will receive all their meals and snacks for the study to ensure accurate comparisons of how these diets impact the gut microbiome.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Beyond Nutrients: NOVA-Defined Dietary Patterns in Crohn's Disease and Healthy Adults.
Lewis A, Ulsamer T, Franco L, Gold S, et al · · 2026 · PMID 41978118 · DOI 10.3390/nu18071068

Verify or expand the search:

Other trials of Mediterranean diet

Trials testing the same drug.

NCT07385716 — Evaluation of the Effect of Time-Restricted Feeding and Mediterranean Diet Model in Women With Polycystic Ovary Syndrome · NA · recruiting
NCT07017127 — Remission of Type 2 Diabetes With Lifestyle Intervention · NA · recruiting
NCT07055620 — Effects of Different Dietary Models on Eating Behavior and Obesity Management in Overweight and Obese Individuals · NA · completed
NCT06774079 — Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) and Diet in Inflammatory Bowel Disease (IBD) Patients · Phase 4 · recruiting
NCT06634316 — Sarcopenia in Patients With Heart Failure · NA · active not recruiting

Other recruiting trials for Healthy

Currently open trials in the same condition.

NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting

Other University of British Columbia trials

Trials by the same sponsor.

NCT07340970 — Sensory Stimuli During Cesarean Delivery · not yet recruiting
NCT07481201 — Phenylalanine Requirements in the Menstrual Phases · NA · not yet recruiting
NCT07492095 — Leucine Requirements in School-Age Children · NA · not yet recruiting
NCT07429305 — Combined Tibial Nerve Stimulation and Standing for People With SCI · NA · recruiting
NCT07519928 — Exploring the Feasibility and Benefits of Implementing Pelvic Floor Muscle Training During Inpatient Rehabilitation for · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06765369 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of British Columbia
Last refreshed: 9 January 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06765369.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing